Weight loss has been shown to improve symptoms in women with PCOS, but achieving and maintaining weight loss can be challenging
The workaround many prescribers use: if a non-diabetic patient also has a comorbidity that a GLP-1 drug treats (cardiovascular disease for Wegovy, sleep apnea for Zepbound), the prescriber can request coverage under that indication
This leads to increased fullness, reduced appetite, and significant weight loss
By healing the mucosal barrier with these specific proteins, you restore your body's natural ability to produce appetite-suppressing hormones
Product documentation may include identity, purity, and related analytical reference information depending on batch and product format
pharmacies based on individual prescriptions